N/A
Completed N=219
Bingocize: A Novel Mobile Application for Older Adult Health
Activities of Daily Living · Accidental Fall · Sarcopenia · Arteriosclerosis
Source: ClinicalTrials.gov NCT03629912 ↗
Enrolled (actual)
219
Serious AEs
5.9%
Results posted
Mar 2024
Primary outcomePrimary: Executive Function Inhibition Measure 1: Flanker Task — 7.30; 7.39; 7.38; 7.51 score on a scale
Summary
This study tests the effectiveness of using a new mobile application (Bingocize®) to improve older adults' (a) adherence to an engaging exercise program, and (b) aspects of functional performance, health knowledge, dietary habits, and cognition.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Executive Function Inhibition Measure 1: Flanker Task |
7.30; 7.39; 7.38; 7.51; 7.66; 7.54 | — |
| PRIMARY Executive Function Measure: Updating Verbal Working Memory |
21.60; 22.42; 22.50; 21.69; 22.56; 22.87 | — |
| PRIMARY Executive Function Measure: Set Shifting Task |
6.70; 6.51; 6.67; 7.05; 6.86; 6.82 | — |
| PRIMARY Executive Function Measure: Verbal Fluency |
9.5; 10.9; 9.04; 10.51; 10.34; 9.97 | — |
| PRIMARY Chair Stands: Change in Lower-body Muscular Strength |
10.07; 9.28; 9.92; 9.94; 11.18; 11.89 | — |
| PRIMARY Change in Dynamic Balance: 360 Degree Turns |
4.62; 4.07; 3.43; 3.37; 4.11; 3.67 | — |
| PRIMARY Executive Function Measure of Inhibition: Continuous Performance Test |
96.76; 96.66; 97.26; 98.17; 96.30; 97.92 | — |
| PRIMARY Timed Up and Go (TUG) Test: Change in Dynamic Balance |
12.58; 12.51; 11.12; 10.96; 12.44; 11.78 | — |
| SECONDARY Crystallized Knowledge of Fall Risks and Proper Diet/Nutrition |
19.45; 19.60; 20.07; 20.12; 23.13; 21.67 | — |
| SECONDARY Grip Strength: Changes in Upper Body Muscular Strength |
23.34; 24.15; 24.00; 23.56; 24.45; 24.80 | — |
| SECONDARY Fall Efficacy Scale |
16.61; 21.00; 19.58; 15.13; 17.68; 20.32 | — |
| SECONDARY Changes in Dietary Habits: Total Added Sugar Intake |
13.46; 14.07; 14.94; 14.09; 13.28; 13.32 | — |
| SECONDARY Changes in Quality of Life |
2.95; 2.83; 2.80; 3.00; 2.86; 2.93 | — |
| SECONDARY Changes in Weight |
84.19; 87.91; 78.11; 86.79; 84.09; 86.83 | — |
| SECONDARY Systolic Blood Pressure |
135.23; 134.03; 136.12; 135.18; 136.25; 143.21 | — |
| SECONDARY Diastolic Blood Pressure |
75.07; 78.23; 76.12; 75.54; 77.14; 79.61 | — |
Eligibility Criteria
Inclusion Criteria
- Normal or corrected normal vision
- Mobility (i.e., not wheelchair bound)
- English is native language
- Minimum physical standards (e.g., ability to walk at least 10 meters)
- No structured physical activity programs >150 minutes/week in last 6 months
Exclusion Criteria
- Severe neurological impairments (e.g., Parkinson's)
- Colorblindness
- Dementia
Data sourced from ClinicalTrials.gov (NCT03629912). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.